Abstract:Approximately 1.2 million people died in 2019 globally due to antimicrobial resistant infections making it one of the major public health issues of the 21st century. Community level antibiotic resistance data is needed for guiding antibiotic prescriptions at the local level, which national databases may be unable to provide. We hypothesized that wastewater could have potential to detect local AMR patterns cost-effectively on a real time and longitudinal basis. Our objectives were to explore the potential of wastewater to detect local AMR patterns of specific Gram Negative bacteria against 4 key antimicrobial classes across Bengaluru city. Wastewater from 66 open storm drain sites within all eight administrative zones of Bengaluru city, in southern India, between March and April 2022 were plated on McConkey and Shigella-Salmonella agar plates. 2 colonies were randomly picked from each plate, identified using standard biochemical tests and then subcultured for antibiotic sensitivity profiles against 5 common antibiotics: ciprofloxacin (Fluoroquinolone), cefixime (3rd generation cephalosporin), piperacillin/tazobactam (TZP, beta lactam/beta lactamase inhibitor), ertapenem and meropenem (carbapenems) on Mueller-Hinton plates Of the 160 isolates selected for deeper scrutiny, 82% (132) belonged to the Enterobacteriaceae family. Of these, 95% (126) were known to cause human infections. About 28% of the clinically relevant Enterobacteriaceae isolates were susceptible to all five antibiotics tested while 12% were resistant to all five antibiotics, and the remainder had a mixed resistance profile. Our results indicate: a) drug resistant bacteria are found in significant numbers in open drains b) there is geographical variation within a city in the patterns and burden of AMR c) Wastewater could be both a method for estimating community burden of AMR. This is the first city-wide wastewater based AMR profiling in India and indicates the potential of such surveillance to provide hyperlocal community level data to influence local antibiotic prescription practices by primary care physicians and on antibiotic purchase and allocation decisions by government drug purchase committees.

Repurposing of drugs against bacterial infections: A pharmacovigilance‐based data mining approach

Drug repurposing for bacterial infections

Drug repurposing against antibiotic resistant bacterial pathogens

Structural-based Study to Identify the Repurposed Candidates Against Bacterial Infections

Improving the treatment of bacterial infections caused by multidrug-resistant bacteria through drug repositioning

Repurposing of Drugs: Updates and New Perspectives

The dark side of drug repurposing. From clinical trial challenges to antimicrobial resistance: analysis based on three major fields

Overcoming antibiotic resistance: the potential and pitfalls of drug repurposing

Drug Repurposing: An Effective Tool in Modern Drug Discovery

Repurposing – second life for drugs

Brief Overview of Approaches and Challenges in New Antibiotic Development: A Focus On Drug Repurposing

System biology approaches for drug repurposing

Innovative Strategies in Drug Repurposing to Tackle Intracellular Bacterial Pathogens

Drug Repurposing Using FDA Adverse Event Reporting System (FAERS) Database

Current approaches in identification of a novel drug targets for drug repurposing

Drug Repurposing: A Leading Strategy for New Threats and Targets

Revitalizing common drugs for antibacterial, quorum quenching, and antivirulence potential against Pseudomonas aeruginosa: in vitro and in silico insights

Drug Repurposing: Far Beyond New Targets for Old Drugs

Implementation of the pharmacovigilance database in the usage of antibiotics in a tertiary care hospital: A pilot study

The First Large-Scale Wastewater Surveillance of AMR to inform Hyperlocal Antibiotic prescribing: A Study from Bengaluru, India

DrugRepo: a novel approach to repurposing drugs based on chemical and genomic features